REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,743 | -99.8% | 4,424 | -99.6% | 0.00% | -100.0% |
Q2 2023 | $28,634,746 | -42.2% | 1,131,361 | -26.4% | 0.05% | -43.9% |
Q1 2023 | $49,514,822 | +145.1% | 1,537,250 | +40.4% | 0.08% | +141.2% |
Q4 2022 | $20,204,912 | +27.7% | 1,094,524 | +86.7% | 0.03% | +21.4% |
Q3 2022 | $15,828,000 | +316460.0% | 586,275 | +151392.2% | 0.03% | – |
Q2 2022 | $5,000 | -87.2% | 387 | -80.7% | 0.00% | – |
Q1 2022 | $39,000 | +30.0% | 2,005 | +6.9% | 0.00% | – |
Q4 2021 | $30,000 | – | 1,875 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |